United States of America
A Rebate Service Working since 2009
Admirals
up to 40% of spread
Partner ID: 35135
Admirals has been a prominent name in the financial markets for nearly two decades, offering traders secure and transparent trading environments. The broker is regulated by top authorities such as FCA (UK), ASIC (Australia), and CySEC (Cyprus), ensuring traders' safety and funds protection through segregated accounts and negative balance protection. Admirals provides over 8,000 tradable instruments across Forex, stocks, indices, commodities, and ETFs, available on MT4 and MT5 platforms enhanced by the unique MetaTrader Supreme Edition and StereoTrader for advanced trading analytics.

News Admirals

March 24, 2020 in 08:00
admiral-markets-investiruyte-v-aktsii-v-oblasti-zdravookhraneniya-image

Trade and invest in health and biotech stocks with Admiral Markets!

The world is on edge as it tries to find a solution to the coronavirus pandemic, with the markets having lost close to 30% in the last few weeks.

We are delighted to announce a small, but important extension of our coverage of the health and biotechnology companies, now available as CFDs (Contracts for Difference) on our Trade.MT5 account:
- Moderna Inc (MRNA)
- DBV Technologies SA - ADR (DBVT)
- Takeda Pharmaceutical Co Ltd - ADR (TAK)

Also, the following common stocks are now available to our clients with Invest.MT5 account:
- Emergent BioSolutions Inc (EBS)
- Biomerica Inc (BMRA)
- BioNTech SE - ADR (BNTX)
- Heat Biologics Inc (HTBX)
- Vaxart Inc (VXRT)
- Vir Biotechnology Inc (VIR)
- Tonix Pharmaceuticals Holding Corp (TNXP)

These instruments join our existing line up of health and biotech stocks, including:

- 102 biotechnology companies, including AbbVie Inc (ABBV), Biogen InC (BIIB), Gilead Sciences Inc (GILD)
- 70 pharmaceutical companies, including Takeda Pharmaceutical Co Ltd (4502.JP), GlaxoSmithKline (GSK), Eli Lilly & Co (LLY), Johnson and Johnson (JNJ), Pfizer (PFE)

Additionally, you can access more than 100 companies in other segments of the healthcare industry plus 13 exchange-traded funds (ETFs) specialised in healthcare & biotech.